𝔖 Bobbio Scriptorium

✦ LIBER ✦

Efficacy of adding insulin therapy to sulfonylurea treatment immediately versus later in the course of progressive β-cell failure in type 2 diabetes

✍ Scribed by R. Paul Robertson

Book ID: 107535883
Publisher: Current Science Inc.
Year: 2002
Tongue: English
Weight: 111 KB
Volume: 2
Category: Article
ISSN: 1534-4827
DOI: 10.1007/s11892-002-0026-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Relative role of insulin resistance and

Relative role of insulin resistance and β-cell dysfunction in the progression to type 2 diabetes—The Kinmen Study

✍ Chia-Lin Li; Shih-Tzer Tsai; Pesus Chou 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 114 KB

PDB50 Long-Term Clinical and Economic Be

PDB50 Long-Term Clinical and Economic Benefit Associated with Liraglutide Versus Sitagliptin Therapy When Added to Metformin in the Treatment of Type 2 Diabetes: a Core Diabetes Model Study

✍ W.C. Lee; Y. Samyshkin; J. Langer; J.L. Palmer 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

Randomized, open-label, parallel-group e

Randomized, open-label, parallel-group evaluations of basal-bolus therapy versus insulin lispro premixed therapy in patients with type 2 diabetes mellitus failing to achieve control with starter insulin treatment and continuing oral antihyperglycemic drugs: A noninferiority intensification substudy of the DURABLE trial

✍ William F. Miser; Richard Arakaki; Honghua Jiang; Jamie Scism-Bacon; Pamela W. A 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 873 KB

PDB54 COMPARISON OF TREATMENT COSTS BETW

PDB54 COMPARISON OF TREATMENT COSTS BETWEEN BASAL-SUPPORTED ORAL THERAPY (BOT) WITH INSULIN GLARGINE (GLA) AND BOT WITH INSULIN DETEMIR (DET) IN PATIENTS WITH TYPE 2 DIABETES (T2D): ECONOMIC EVALUATION BASED ON THE RESULTS OF THE INSULIN GLARGINE (LANTUS®) VERSUS INSULIN DETEMIR (LEVEMIR®) TREAT-TO-TARGET (L2T3) STUDY

✍ PK Schädlich; KC Koltermann; FW Dippel; EG Hagenmeyer; B Häussler 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB